Asthmanefrin Racephinephrine Inhalation Solution Recalled Due to Improper Storage
Asthmanefrin Racephinephrine Inhalation Solution is being recalled because batches were stored outside the conditions specified on the drug label. The recall affects products distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or deaths. The recall is due to a CGMP compliance deviation (improper storage) without documented safety incidents, qualifying it as a quality control matter rather than an active safety threat.
Plain-English summary
Asthmanefrin Racephinephrine Inhalation Solution, a bronchodilator for temporary relief of mild symptoms of intermittent asthma, is being recalled. The recall affects products distributed nationwide in the United States.
The product is being recalled due to a CGMP (good manufacturing practices) deviation: products were stored outside the conditions specified on the drug label. This storage deviation was identified by McKesson Medical-Surgical Inc., the recalling firm.
Consumers who have obtained this product should consult with their healthcare provider or pharmacist regarding whether continued use is appropriate.
The recalled product
- Product
- Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug
- Hazard
- improper-storage
- cgmp-deviation
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22